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Abstract
Background: Diabetes mellitus is a major global health issue with a growing prevalence. In this context, the
number of diabetic complications is also on the rise, such as diabetic foot ulcers (DFU), which are closely linked to
the risk of lower extremity amputation (LEA). Statistical prediction tools may support clinicians to initiate early
tertiary LEA prevention for DFU patients. Thus, we designed Bayesian prediction models, as they produce
transparent decision rules, quantify uncertainty intuitively and acknowledge prior available scientific knowledge.
Method: A logistic regression using observational collected according to the standardised PEDIS classification was
utilised to compute the six-month amputation risk of DFU patients for two types of LEA: 1.) any-amputation and 2.)
major-amputation. Being able to incorporate information which is available before the analysis, the Bayesian models
were fitted following a twofold strategy. First, the designed prediction models waive the available information and,
second, we incorporated the a priori available scientific knowledge into our models. Then, we evaluated each
model with respect to the effect of the predictors and validity of the models. Next, we compared the performance
of both models with respect to the incorporation of prior knowledge.
Results: This study included 237 patients. The mean age was 65.9 (SD 12.3), and 83.5% were male. Concerning the
outcome, 31.6% underwent any- and 12.2% underwent a major-amputation procedure. The risk factors of perfusion,
ulcer extent and depth revealed an impact on the outcomes, whereas the infection status and sensation did not.
The major-amputation model using prior information outperformed the uninformed counterpart (AUC 0.765 vs AUC
0.790, Cohen’s d 2.21). In contrast, the models predicting any-amputation performed similarly (0.793 vs 0.790,
Cohen’s d 0.22).
Conclusions: Both of the Bayesian amputation risk models showed acceptable prognostic values, and the major-
amputation model benefitted from incorporating a priori information from a previous study. Thus, PEDIS serves as a
valid foundation for a clinical decision support tool for the prediction of the amputation risk in DFU patients.
Furthermore, we demonstrated the use of the available prior scientific information within a Bayesian framework to
establish chains of knowledge.
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Background
Diabetes mellitus is a major global health issue [1, 2].
Reflected by the high prevalence rates in the past [3–5],
diabetes presently is and presumably will remain a sig-
nificant challenge for societies and health systems world-
wide, as studies forecast increasing prevalence rates for
the upcoming years [6–8].
Along with high prevalence rates, the number of dia-
betic complications also increases [9], among them are
diabetic foot ulceration (DFU) [10]. Closely linked to the
risk of lower extremity amputation, DFU causes
imminent disease burden, high costs [11, 12] and high
mortality rates [13–15]. While, in medical care and nurs-
ing, the prevention of DFU should be the primary im-
perative [16], it is essential to identify DFU patients with
a high amputation risk early in order to initiate close
ulcer monitoring and care, including amputation-
preventive actions. In this context, ensuring comparable
clinical statements about ulcers, standardised classifica-
tion systems are used for cross-sectional and longitu-
dinal ulcer documentation. Those classifications are
widely used in routine clinical care and research. Exist-
ing studies that have investigated the prognostic value of
these classifications in DFU care promised to provide a
foundation for decision support systems used for ampu-
tation risk modelling [17, 18]. For example, as part of
the multi-centre EURODIALE initiative, Pickwell et al.
developed a well-performing risk assessment tool for
amputation based on the PEDIS classification [18]. PEDI
S reliably describes [19–21] diabetic foot according to
five categories, i.e. risk factors, which form the respective
acronym: perfusion status, extent of ulcer, depth of
ulcer, infection status and sensation [19, 22] (see
Table 1). In the approach of Pickwell et al., each cat-
egory is assessed, scored and then aggregated to a final
sum so that a larger overall score correlates with higher
amputation risk.
In contrast, prognostic systems developed with statistical
modelling techniques may achieve higher validity compared
to scoring systems. Furthermore, and opposed to sum
scores, these statistical models can compute a probability
value expressing the amputation risk, whose interpretation
might be more convenient for clinicians [24].
In this light, we aimed to design prediction models
based on the PEDIS classification using a logistic regres-
sion model, which computes the probability value for
the amputation. For model development, a Bayesian
modelling approach lends itself because it offers funda-
mental advantages that are important in the domain of
clinical predictive modelling. First, Bayesian models are
transparent as they provide model details represented by
complete probability distributions about estimated
model parameters, statistical metrics, such as AUC
values, and predictions [25, 26]. This yields transparency,
allowing clinical users of a model to understand the de-
cision rules and better grasp the predicted results in
order to embody them into their clinical reasoning and
clinical action safely [27, 28].
Second, Bayesian models can incorporate a priori
knowledge, i.e. information about the model parameters
available before the analysis. This fundamental feature
enables Bayesian analysis to serve as a framework for a
learning health system characterised by a collaborative,
interorganisational, data-driven research process [29,
30]. In this way, without sharing sensitive patient data,
researchers can directly incorporate prior available sci-
entific information into their statistical models, thereby
accumulating knowledge by statistically combining exist-
ing research and their data. Still, this requires similar re-
search questions and standardised structured data across
research initiatives. As the PEDIS classification is a stan-
dardised and widely accepted classification system, it
serves as a useful showcase in developing and validating
Bayesian predictive models for clinical decision making.
Thus, this study follows three research questions: First,
what is the effect of each of the PEDIS risk factors on
the outcome, i.e. amputation? Second, what is the prog-
nostic value of PEDIS prediction models? Furthermore,
we intend to investigate the impact of prior knowledge.
Therefore, we plan to design and compare models that
Table 1 We used the PEDIS classification system developed by the International Working Group on the Diabetic Foot (IWGDF).The
table gives an overview of the PEDIS classification. For more detail, please refer to Schaper (2004) [23]. Additional information about
the PEDIS assessment is given in the method section of this study
Grade/
Score




< 1 cm2 Superficial No symptoms or sign of infection No loss of
protective
sensation






Infection involving the skin and the subcutaneous tissue only Loss of
protective
sensation
3 CLI > 5 cm2 Bone or
joint
Erythema > 2 cm plus one of: swelling, tenderness, warmth, discharge; or
infection involving structures deeper than skin and subcutaneous tissues
4 Systemic inflammatory response syndrome (SIRS)
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waive prior knowledge with models that incorporate avail-
able knowledge. Accordingly, the third research question
is: Does the incorporation of prior available scientific
knowledge improve the prognostic value of the models?
Methods
Study design and sample
We conducted an observational, prospective single-
centre, open cohort study, including Diabetes Mellitus
(DM) patients with a diabetic foot ulcer (DFU).
The study pursued a prospective study design, as the
data collection and analysis were planned before the eli-
gible subjects were studied. The investigation was con-
ducted at a specialised wound care centre as part of the
traumatic surgery unit of Klinikum Melle in Germany,
which is a partner in a local learning health system. Data
capture started on 1st June 2013 and ended on 1st July
2019. We recruited male and female type 1 and 2 dia-
betes patients who were over 18 years old. The exclusion
criteria were traumatic wounds, tumour-induced ulcers
and patients without DM. GH screened all inpatient and
outpatient subjects with DFU before study entry.
At baseline, GH, JHe, and SW assessed all the included
patients according to the PEDIS classification (IWGDF)
as described by Schaper [23]. To obtain the perfusion
status, for which different methods are described [23],
e.g. assessing the tcoO2 value, we used the blood pres-
sure as an indicator, i.e., the Ankle Brachial Pressure
Index (ABPI) and systolic ankle pressure. To obtain the
sensation, we used 10 g-monofilament (on three sites of
the plantar foot) and a 128 Hz tuning fork on the hallux.
When a patient had more than one ulcer, we chose the
one with the highest PEDIS score as the index ulcer.
Gender and age at baseline were collected s demo-
graphic variables. After the baseline assessment, patients
were treated in the wound care centre according to the
national clinical guidelines [31] by an interdisciplinary
team of physicists (surgeons, diabetologists, cardiolo-
gists), specialised nurses, physiotherapists, podiatrists.
To ensure an optimal healing situation, an external
orthopaedic technician supplied patients with individual
offloading systems on-site in close collaboration with the
wound care centre. Six months after each patient’s base-
line assessment, we determined the final treatment out-
comes as any-amputation (ICD-9 CM code: 84.13–84.19
and 84.11–84.12) and major-amputation (amputations
above the ankle ICD-9 CM code 84.11–84.12), however,
as in accordance with Pickwell et al. [18], excluding the
lesser toes.
Statistical analysis
To answer the first two research questions, Bayesian
models were fitted using the five PEDIS risk factors as
the predictors as well as age and gender as the
covariates. Each of the clinical outcomes served as the
criterion. With regard to the third research question, fo-
cusing on the effect of prior knowledge, we followed a
twofold strategy. First, we created models for both out-
comes waiving prior knowledge. Second, we fitted the
same models, but in this step, we incorporated the avail-
able information.
We used prior information for three main reasons: First,
prior knowledge helps to make more reliable inferences
when only a small amount of data is available. Second, as
prior knowledge mainly represents external scientific
knowledge, it is especially useful for our risk models as we
utilised data from a single wound care centre. Third, as
the role of the PEDIS risk factors is established in clinical
care and research, a models waiving prior information
neglect existing knowledge and would stand against the
Bayesian reasoning, encouraging the use of the available
knowledge in these situations [25, 32].
The priors were designed with Cauchy distributions as
proposed by Gelman et al. [33]. In the first approach, i.e.
modelling without prior information, we assigned a
zero-centred Cauchy distribution with a broad scale of 1
to each predictor, spanning a vast range of prior plaus-
ible model coefficients. In the second case, i.e. with
knowledge, odds ratios and corresponding confidence
intervals (CI) were derived from the published data in
the study of Pickwell et al. [18] which were then pooled
and further adjusted by subtracting the standard error
twice. Thereby, the odds ratios were designed as conser-
vative prior estimates reflecting the general pattern of
external knowledge. The log-transformed odds ratios
were then integrated as parameters into informative
Cauchy distributions for the Bayesian logistic regression.
Figure 1 illustrates the implemented prior distributions.
The Monte Carlo Markov Chain (MCMC) sampling
procedure was used to fit the Bayesian models, and for the
computation of the posterior distributions, the open-
source R-package rstanarm (version 2.19.2) was used [34].
For each model, we generated four MCMC chains with
8500 steps and set the burn-in period to 500 iterations,
yielding 30,000 sample MCMC steps for each model.
To make inferences about the effect of the risk factors
on the outcome, 95% Highest Density Intervals (HDI)
were computed as credible intervals, which are common
in Bayesian statistics [25, 35]. Any value within the inter-
val has a higher density than the values outside, and the
total mass of values inside is 95%. As the HDI contains
the 95% most credible posterior values of the predictor,
it is considered to be associated with the outcome when
the HDI excludes the null value [35, 36]. For beta-
coefficients, the null value is zero, but it is also common
to exponentiate beta coefficients in logistic regression,
whereby they can be interpreted as odds ratios [37]. In
this case, the null value is one.
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We used the programming language R (version 3.6.2)
and additional open-source R-packages for all the statis-
tical analyses [34, 38–40].
Results
Sample description
A total of 254 patients met the inclusion criteria and were
recorded at baseline (admission to the wound care centre
and inpatients). Sixteen patients were lost to follow-up
(deceased or dropped out due to other reasons, e.g.
moved), which resulted in 237 study participants.
The mean age of the sample was 65.9 (SD 12.3) years.
The proportion of female and male patients was 16.5
and 83.5%, respectively. Among all the patients, 31.6%
(n = 75) had at least any-amputation (excluding lesser
toes) and 12.2% (n = 29) underwent a major-amputation
procedure (Table 2).
Model diagnostics
We reviewed the Markov Chain Monte Carlo (MCMC)
sampling procedure of the Bayesian logistic regression
models for convergence, autocorrelation, effective sam-
ple size (ESS) and collinearity. The chain of each coeffi-
cient converged, lacked autocorrelation and showed a
large effective sample size (> 10,000) for all the model
coefficients (see Additional file 1). The covariate matrix
revealed an absence of collinearity (see Additional file 2).
Univariate models, which were calculated to explore the
relationships, showed that perfusion, extent and depth
had an impact on the outcome while infection and
Fig. 1 A histogram matrix of the posterior coefficient distributions of all four model. Each column shows a model; each row shows a risk factor.
The light blue histograms show the posterior distributions. The light grey density curves represent the prior probability distribution of the models.
The black error bar shows the 95% highest density interval (HDI). The black square in the middle of the error bar represents the posterior median
estimate of the model coefficients. The dotted vertical line represents the null-value of 0, which, when exponentiated, corresponds to an OR of
1). Risk models: column a uninformed any-amputation; column b informed any-amputation; column c uninformed major-amputation; column d
informed major-amputation
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sensation were unconnected with the outcome (see Add-
itional file 3). Based on the MCMC sample, we were able
to compute the posterior coefficient distributions, pos-
terior AUC distributions as well as distribution of the
predictions (Script available in Additional file 4).
Models without prior knowledge
The any-amputation risk model provided significant evi-
dence of a positive effect of perfusion status, ulcer extent
and ulcer depth as their 95% HDI excluded the null
value (Table 3). In contrast, the 95% HDI of infection
status and loss of sensation covered the null value and
thus indicated no impact.
The major-amputation risk model lacked significant
evidence of an effect of any PEDIS risk factor as their
95% HDIs included the null value. However, the propor-
tion of posterior coefficient values below zero for perfu-
sion, extent and depth was 2.7, 2 and 2.2%, respectively,
which hints at a positive relationship as most posterior
values cluster above zero (Fig. 1 and Table 3).
Concerning the prognostic value, the receiver operat-
ing characteristic analysis of the posterior AUC
distributions showed a posterior median estimate of
0.793 (95% HDI 0.778–0.801) for any-amputation and
0.765 (95% HDI 0.725–0.779) for major-amputation.
Comparing both AUC values (Δ = 0.031), the former
model revealed a higher predictive value.
Models including prior knowledge
To evaluate the impact of informative priors, we compared
the Bayesian models, which used a neutral prior and were
presented in the last sections, with models which incorpo-
rated external, a priori available scientific knowledge.
The informative priors had an impact on the major-
amputation risk model, which mainly led to a decreased
variance in the posterior coefficient distribution (Table
3). As a result, the informed model revealed three non-
null predictors: perfusion status, ulcer extent and depth.
The decreased variance also affected the predictive value
of the informed model for the outcome major-
amputation: Yielding a large effect size (Cohen’s d =
2.217), the difference between both AUC values (Δ =
0.029) suggested that the informed model outperformed
the uninformed counterpart (AUC: 0.765 vs 0.790).
Table 2 Descriptive summary of the age, gender, the PEDIS sum score and each of the PEDIS risk factors for the overall sample,
any-amputation and major-amputation status. Data are shown in per cent; except the PEDIS sum score and age, which are
summarised by the mean. The final count of any-amputees is the sum of the minor- (n = 46) and major amputations (n = 29)
Characteristic Grade/ Score Overall Sample Any-Amputation Major-Amputation
Non Amputees
(n = 162, 68.4%)
Amputees*
(n = 75, 31.6%)
Non Amputees
(n = 208, 87.8%)
Amputees
(n = 29, 12.2%)
Proportion Frequency (n = 237) Proportion n Proportion n Proportion n Proportion/ Mean n
Gender Female 16.46% 39 12.24% 29 4.22% 10 14.77% 35 1.69% 4






















208 12.17(SD 1.4) 29
Perfusion Stage 1 48.1% 114 40.93% 97 7.17% 17 45.57% 108 2.53% 6
Stage 2 32.49% 77 20.25% 48 12.24% 29 27.85% 66 4.64% 11
Stage 3 19.41% 46 7.17% 17 12.24% 29 14.35% 34 5.06% 12
Extent Stage 1 3.38% 8 3.38% 8 0% 0 3.38% 8 0% 0
Stage 2 31.22% 74 28.27% 67 2.95% 7 30.38% 72 0.84% 2
Stage 3 65.4% 155 36.71% 87 28.69% 68 54.01% 128 11.39% 27
Depth Stage 1 5.91% 14 5.06% 12 0.84% 2 5.91% 14 0% 0
Stage 2 32.91% 78 28.27% 67 4.64% 11 31.65% 75 1.27% 3
Stage 3 61.18% 145 35.02% 83 26.16% 62 50.21% 119 10.97% 26
Infection Stage 1 36.29% 86 26.16% 62 10.13% 24 33.76% 80 2.53% 6
Stage 2 35.44% 84 22.78% 54 12.66% 30 29.54% 70 5.91% 14
Stage 3 25.74% 61 18.14% 43 7.59% 18 22.78% 54 2.95% 7
Stage 4 2.53% 6 1.27% 3 1.27% 3 1.69% 4 0.84% 2
Sensation Stage 1 7.17% 17 5.49% 13 1.69% 4 6.75% 16 0.42% 1
Stage 2 92.83% 220 62.87% 149 29.96% 71 81.01% 192 11.81% 28
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Opposed to the major-amputation models, the
bottom-line finding for the any-amputation models
remained the same: the 95% HDI of perfusion, extent
and depth excluded the neutral value of zero (which cor-
responds to the neutral odds ratio of 1 when exponen-
tiated), whereas those for infection and sensation did not
(Table 3 and Fig. 1). The posterior median estimates for
the coefficients and the AUC remained nearly constant,
e.g. AUC: 0.793 vs 0.790 (Cohen’s d = 0.224, Δ = 0.003).
Model application for decision support
The results of these models can be visualised for clinical
use to support decision making. Figure 3 shows the dis-
tributions of the predicted probabilities for any-
amputation using the informed model for two hypothet-
ical ulcers classified according to the PEDIS system. In
the first case, the PEDIS classification describes a rather
moderate ulcer. In this first example, the patient has a
peripheral arterial disease but no critical limb ischaemia
(stage 2/3), an ulcer extent ranging between one and five
cm2 (stage 2/3), but just a superficial ulcer (stage 1/3),
no signs of infection (stage 1/4) and the presence of pro-
tective sensation (stage 1/2). In this case, the model
computes a median posterior amputation risk of 4.4%
(95% HDI 0.2–13%). The second example describes a
more severe ulcer, i.e. the limb perfusion is critical due
to ischaemia (stage 3/3), the ulcer extends > five cm2
(stage 3/3) and it reaches deep tissues (stage 3/3), and
infection (stage 1/4) and sensation status (stage 1/2)
(Table 1). In this case, the median posterior risk estimate
was 63% (95% HDI 37.2–85.9%).
The model clearly discriminates between both diabetic
ulcers predicting a lower risk for the former compared
to the latter which is not only indicated by the median
risk prediction but also in the non-overlapping HDIs.
Furthermore, the posterior variability quantified by the
HDI expresses the associated uncertainty of the pre-
dicted risk: The range of the 95% HDI of the former ex-
ample is nearly four times narrower than that of the




In the present study, we developed amputation risk models
based on the PEDIS classification system using Bayesian
statistics. Bayesian approaches are becoming more popular
in applied research [41] and they open an entirely new av-
enue for the interpretation of model parameters and enable
the establishment of chains of knowledge by incorporating
prior available scientific information.
Including 237 patients with DFU, we examined the effect
of each PEDIS risk factor and the outcome variables any-
and major-amputation. Furthermore, we conducted a re-
ceiver operating characteristic analysis to assess the prog-
nostic value of the models. In summary, except for the
non-informed major-amputation model, the posterior coef-
ficient distributions of the other models revealed a positive
effect of the three predictors: perfusion status, ulcer extent
and ulcer depth. Among both outcomes, the PEDIS risk
model for any-amputation had a slightly higher prognostic
value compared to the risk model for major-amputation.
In addition, we investigated the impact of prior available
scientific knowledge on the association of PEDIS risk fac-
tors with the outcomes as well as on the predictive value
of the models. The major-amputation risk model could be
Table 3 Summary of the four PEDIS risk models. To support a more straightforward interpretation of the logistic regression model
coefficients, we present them as odds ratios (OR) in this table; the logistic regression coefficients can be interpreted as odds ratios
when exponentiated. The OR is the exponentiated median of the posterior coefficient distribution. Furthermore, the 95% HDI of
the OR is presented. HDI is derived from the posterior distribution. Any value within the interval has a higher density than the




Any Amputation Major Amputation
Non-Informed Model Informed Model Non-Informed Model Informed Model

















































































AUC Value 0.793 0.790 0.765 0.790
AUC HDI [0.778–0.801] [0.774–0.802] [0.725–0.779] [0.774–0.802]
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improved through the inclusion of prior information,
which manifested in non-null coefficients (perfusion sta-
tus, ulcer extent and ulcer depth) and improved the prog-
nostic value. In contrast, prior incorporated knowledge
had no impact on the any-amputation risk model.
Our risk models did not provide enough evidence of
an impact of the two remaining PEDIS risk factors infec-
tion status and sensation. This stands in contrast with
previous studies [42] but confirms our univariate find-
ings. However, as the risk factor infection is a red flag, it
may have facilitated close ulcer monitoring and attentive
care as an amputation protective measure. Furthermore,
this finding may be the result of the categorical design
of the PEDIS risk factors and the loss of information that
obviously affected these two factors most. For example,
the sensory status is binary, e.g. presence or loss of pro-
tective sensation, which reflects a rather coarse represen-
tation of information. More detailed measurement
approaches, e.g. the monofilament test, could provide
more information for a predictive risk model. However,
the PEDIS system was designed as a DFU classification
system rather than a tool supporting risk models, which
explains the categorical design.
With respect to validity, AUC values ranging from 0.7
to 0.8 are considered acceptable [43, 44]. Thus, our risk
models may be useful as clinical decision support tools to
screen and stratify patients according to their six-month
amputation incidence risk. Among the uninformed
models, the PEDIS classification had a higher predictive
value for any-amputation compared to major-amputation,
as indicated by the AUC values (0.793 vs 0.765).
Incorporating prior information and thus reducing the
variance, we were able to increase the predictive value of
the major-amputation model (AUC: 0.766 vs 0.790).
Bayesian modelling and clinical impact
In this study, we chose to analyse the data using Bayes-
ian modelling to make use of three key features that are
not available for classical statistical techniques:
Fig. 2 The posterior distributions of the AUC values. The error bars show the 95% highest density interval. The black square of each error bar
shows the posterior AUC median estimate. Risk models: a uninformed any-amputation; b informed any-amputation; c uninformed major-
amputation; d informed major-amputation
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First, as described in the previous section, we took ad-
vantage of available prior knowledge about DFU risk fac-
tors. Second, a further advantage of the Bayesian
framework is that it can be seen in a diachronic light. In
this context, a Bayesian model evolves through time: As
new data becomes available, the posterior distributions
serve as informed priors to a consecutive Bayesian ana-
lysis. This approach opens the door of pooling model in-
formation across institutions without sharing sensitive
patient information but only the posterior coefficient
distributions. To promote this feature, we published the
posterior distributions of the presented models. Third,
opposed to classical models which commonly provide a
single point estimate and a confidence interval, Bayesian
models provide richer information, such as the distribu-
tion of the model coefficients (Fig. 1) and the AUC value
(Fig. 2). Moreover, the distribution of the predicted
values is available. Presenting the predictions in this way
(Fig. 3), trained clinicians obtain more information from
the distribution, such as the most probable estimated
risk and the uncertainty associated with this estimate.
Moreover, the interpretation of the posterior distribution
could be more intuitive compared to classical estimates,
such as confidence intervals [45]. In this context, the
Bayesian framework may provide a sound basis for fu-
ture transparent clinical decision support. As they
require calculations based on the MCMC samples, such
decision support cannot be provided manually but
should rather be embedded in digital software products
used in daily clinical routine. Furthermore, clinicians
need to be trained to make appropriate use of uncer-
tainty and the interpretation of intervals.
Limitations
The findings should not be interpreted without knowing
the specific limitations of this study. The study is based
on a comparably small sample size, which we collected
in a single wound care centre. This raises concerns
about their external validity. This deficiency can be miti-
gated via the Bayesian approach of integrating the exist-
ing available scientific knowledge via prior distributions,
which was exercised successfully in this study. To ac-
count for limited comparability, we designed our priors
to be conservative estimates of a priori knowledge. More
studies of this kind with more specific and detailed prior
information than incorporated into this study would fur-
ther enhance the generalisability of these findings while
preserving the local findings. These local findings might
have their own right and usefulness within the context
of a local learning health system where local populations
are of interest.
Fig. 3 Example of the posterior distributions of the predicted amputation risk based on the informed any-amputation risk model. The solid dot
and the error bar indicate and the corresponding posterior median risk estimate and the 95% HDI. The amputation risk for the lower PEDIS
classification is 4.4% [95% HDI 0.2–13%] and for the higher PEDIS classification 63% [95% HDI 37.2–85.9%]
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We aimed to examine the prognostic value of the
PEDIS system because it is a widely applied and ac-
cepted classification in clinical DFU care. Although the
AUC values of the PEDIS risk models are considered ac-
ceptable, they should be used carefully in clinical deci-
sion processes because it is important to remember that
the primary use case for the PEDIS system is DFU classi-
fication rather than prediction. Thus, to further improve
the prognostic value of a risk model, additional DFU
characteristics may be helpful, e.g. ulcer history and
diabetes onset, which we did not include. Further-
more, future risk models should also consider psycho-
social variables as they are closely linked to DFU
healing [46–48].
Conclusion
In summary, we developed PEDIS risk models predicting
the six-month amputation risk for any- and major-
amputation using a Bayesian framework. Among the
PEDIS risk factors, perfusion status, ulcer extent and
ulcer depth were most closely related to both amputa-
tion outcomes. Both amputation risk models showed ac-
ceptable prognostic accuracy but needed additional
information to be incorporated for improving the clinical
prognostic values. Furthermore, we encourage future re-
search initiatives with related scientific goals to make
use of our Bayesian posterior distributions and embody
them in their own Bayesian analysis.
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